Literature DB >> 22353523

Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients.

Toru Mizuguchi1, Masaki Kawamoto, Makoto Meguro, Seiichi Son, Yukio Nakamura, Kohei Harada, Toshihito Shibata, Shigenori Ota, Koichi Hirata.   

Abstract

BACKGROUND/AIMS: Evaluation of preoperative hepatic reserve is critical to avoid a fatal clinical course such as liver failure. We retrospectively evaluated 158 consecutive hepatocellular carcinoma (HCC) patients who underwent initial hepatectomy. The aim of this study was to determine the correlations of multiple indicators for assessment of liver function before hepatectomy. Furthermore, diagnostic probability for the pathological background and prediction of postoperative liver failure/dysfunction was compared between the antithrombin (AT) III level and indocyanine green retention rate at 15 minutes (ICGR15).
METHODOLOGY: Between January 2001 and March 2008, 158 HCC patients who underwent initial hepatectomy were enrolled in this study. Spearman's correlation coefficients (r values) were obtained for 15 clinical laboratory tests including ATIII and ICGR15. Receiver operating characteristic (ROC) curve analysis was used for calculating the probability and predictive ability of the tests.
RESULTS: All 158 consecutive HCC patients were eligible for hepatectomy based on the Japanese guideline. ATIII is correlated with 13 of 14 other clinical tests, including albumin, bilirubin, prothrombin time, rapid turnover proteins, HGF, ICGR15 and others. The diagnostic probabilities to distinguish between normal liver and other pathological backgrounds of ATIII and ICGR15 were significantly different. The specificity of ATIII to predict postoperative liver failure/dysfunction was higher than that of ICGR15.
CONCLUSIONS: The serum ATIII level before hepatectomy is valuable to estimate the pathological background and predict postoperative liver failure/ dysfunction. It should be possible to use ATIII as an additional indicator for liver function and substitute for ICGR15 in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22353523     DOI: 10.5754/hge10052

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Prognosis and predictors of surgical complications in hepatocellular carcinoma patients with or without cirrhosis after hepatectomy.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Yukio Nakamura; Shigenori Ota; Thomas T Hui; Koichi Hirata
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 2.  Preoperative liver function assessments to estimate the prognosis and safety of liver resections.

Authors:  Toru Mizuguchi; Masaki Kawamoto; Makoto Meguro; Thomas T Hui; Koichi Hirata
Journal:  Surg Today       Date:  2013-03-09       Impact factor: 2.549

3.  Discovery of a Potential Plasma Protein Biomarker Panel for Acute-on-Chronic Liver Failure Induced by Hepatitis B Virus.

Authors:  Ni Zhou; Kuifeng Wang; Shanhua Fang; Xiaoyu Zhao; Tingting Huang; Huazhong Chen; Fei Yan; Yongzhi Tang; Hu Zhou; Jiansheng Zhu
Journal:  Front Physiol       Date:  2017-12-06       Impact factor: 4.566

4.  Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity.

Authors:  David Pereyra; Florian Offensperger; Florian Klinglmueller; Stefanie Haegele; Lukas Oehlberger; Thomas Gruenberger; Christine Brostjan; Patrick Starlinger
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

5.  Effects of Serum Albumin Levels on Antithrombin Supplementation Outcomes Among Patients With Sepsis-Associated Coagulopathy: A Retrospective Study.

Authors:  Masatomo Ebina; Kazunori Fujino; Akira Inoue; Koichi Ariyoshi; Yutaka Eguchi
Journal:  Clin Med Insights Blood Disord       Date:  2019-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.